The next Baltimore Science Cafe will be an evening conversation about CRISPR, the hot new genome editing technology on the block. It makes inserting, deleting or modifying genes cheap, quick, and simple. This has been an incredible boon to biomedical scientists, who can create animals and cells with targeted changes for both basic and therapeutic research. Clinicians are also looking at CRISPR technology for use in treating disease. Dr. Joel Pomerantz, an immunology researcher, and Dr. Debra Mathews, a clinical ethicist, will hold a panel conversation on the future of CRIPSR to discuss the many questions about the ethics and impact of genome editing.
Check out Project Bridge at http://www.projbridge.com/